Clinical use of instruments that measure peripheral bone mass

Current Opinion in Endocrinology and Diabetes

Volumn 9, Issue 6, 2002, Pages 502-511

  Blake, Glen M ^a   Fogelman, Ignac ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY; BONE GROWTH; BONE MASS; BONE MINERAL; COMPUTER ASSISTED TOMOGRAPHY; DEVICE; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; EQUIPMENT; EVALUATION; FEMUR; FRACTURE; HUMAN; INTERMETHOD COMPARISON; NORMAL DISTRIBUTION; OSTEOPOROSIS; PREDICTION; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; SPINE; TECHNIQUE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 0038687012     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200212000-00010     Document Type: Review

References (72)

1. Kanis JA, Delmas P, Burckhardt P, et al.: Guidelines for diagnosis and treatment of osteoporosis. Osteoporosis Int 1997, 7:390-406.
2. Baran DT, Faulkner KG, Genant HK, et al.: Diagnosis and management of osteoporosis: guidelines for the ultilization of bone densitometry. Calcif Tissue Int 1997, 61:433-440.
3. Jacobsen SJ, Goldberg J, Miles TP, et al.: Race and sex differences in mortality following fracture of the hip. Am J Public Health 1992, 82:1147-1150.
4. Koval KJ, Skovron ML, Ahanonoff GB, et al.: Ambulatory ability after hip fracture: a prospective study in geriatric patients. Clin Orthop 1995, 310:150-159.
5. Ray NF, Chan JK, Thamer M, et al.: Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997, 12:24-35.
6. Gabriel SE, Tosteson ANA, Leibson CL, et al.: Direct medical costs attributable to osteoporotic fractures. Osteoporosis Int 2002, 13:323-330. A population based study of the additional medical costs incurred as a consequence of an osteoporotic fracture.
7. 3 and calcium to prevent fractures in elderly women. N Engl J Med 1992, 327:1637-1642.
8. Black DM, Cummings SR, Karpf DB, et al.: Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996, 348:1535-1541.
9. Cummings SR, Black DM, Thompson DE, et al.: Effect of alendronate on risk of fracture in women with low bone density but without vertebral fracture: results from the Fracture Intervention Trial. JAMA 1998, 280:2077-2082.
10. Ettinger B, Black DM, Mitlak BH, et al.: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999, 282:637-645.
11. Harris ST, Watts NB, Genant HK, et al.: Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 1999, 282:1344-1352.
12. Reginster J-Y, Minne HW, Sorensen OH, et al.: Randomised trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporosis Int 2000, 11:83-91.
13. Chesnut CH, Silverman S, Andriano K, et al.: A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 2000, 109:267-276.
14. McClung MR, Geusens P, Miller PD, et al.: Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001, 344:333-340. The only completed trial to date in which prevention of hip fracture was the primary endpoint of the study. Fracture prevention was reported only for patients with a baseline hip T-score less than -3.
15. Neer RM, Arnaud CD, Zanchetta JR, et al.: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001, 344:1434-1441. The largest completed trial to date of PTH treatment for osteoporosis. Study showed that the larger increases in BMD obtained with PTH compared with other treatments is accompanied by improved fracture prevention.
16. Reid IR, Brown JP, Burckhardt P, et al.: Intravenous zolendronic acid in postmenopausal women with low bone mineral density. N Engl J Med 2002, 346:653-661. First large trial of zolendronate. Patients given zolendronate by IV injection once yearly did and those treated more frequently.
17. World Health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva: WHO; 1994.
18. Kanis JA, Melton LJ, Christiansen C, et al.: The diagnosis of osteoporosis. J Bone Miner Res 1994, 9:1137-1141.
19. Glüer C-C, Jergas M, Hans D. Peripheral measurement techniques for the assessment of osteoporosis. Semin Nucl Med 1997, 27:229-247.
20. Njeh CF, Boivin CM, Langton CM. The role of ultrasound in the assessment of osteoporosis: a review. Osteoporosis Int 1997, 7:7-22.
21. Greenspan SL, Bouxsein ML, Melton ME, et al.: Precision and discriminatory ability of calcaneal bone assessment technologies. J Bone Miner Res 1997, 12:1303-1313.
22. Augat P, Fuerst T, Genant HK. Quantitative bone mineral assessment at the forearm: a review. Osteoporosis Int 1998, 8:299-310.
23. Schneider P, Reiners C, Cointry GR, et al.: Bone quality parameters of the distal radius as assessed by pQCT in normal and fractured women. Osteoporosis Int 2001, 12:639-646. A comprehensive assessment of the clinical performance of a pQCT device in women who had suffered a Colles fracture compared with controls. The study emphasises the clinical potential of the biomechanical indices obtained by pQCT.
24. Njeh CF, Fuerst T, Fan B, et al.: Is quantitative ultrasound dependent on bone structure? A reflection. Osteoporosis Int 2001, 12:1-15. A useful review of the long running controversy on whether QUS measurements reflect bone microarchitecture or are simply a surrogate for BMD.
25. Prevrhal S, Fuerst T, Fan B, et al.: Quantitative ultrasound of the tibia depends on both cortical density and thickness. Osteoporosis Int 2001, 12:28-34. A study which shows that semi-reflective QUS measurements of SOS depend on cortical thickness and cortical density.
26. Damilakis J, Perisinakis K, Gourtsoyiannis N. Imaging ultrasonometry of the calcaneus: optimum T-score thresholds for the identification of osteoporotic subjects. Calcif Tissue Int 2001, 68:219-224.
27. Frost ML, Blake GM, Fogelman I. Quantitative ultrasound and bone mineral density are equally associated with risk factors for osteoporosis. J Bone Miner Res 2001, 16:406-416. QUS measurements of the heel are shown to be equally responsive to clinical risk factors for osteoporosis as conventional spine and femur BMD. An important result for when a case finding strategy is used for patient referral.
28. Rosholm A, Hyldstrup L, Baeksgaard L, et al.: Estimation of bone mineral density by digital X-ray radiogrammetry. Osteoporosis Int 2001, 12:961-969. Useful technical description of the recently introduced digital radiogrammetry technique.
29. Cann CE. Quantitative CT for determination of bone mineral density: a review. Radiology 1988, 166:509-522.
30. Genant HK, Engelke K, Fuerst T, et al.: Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 1996, 11:707-730.
31. Blake GM, Fogelman I. Technical principles of dual energy x-ray absorptiometry. Semin Nucl Med 1997, 27:210-228.
32. Blake GM, Wahner HW, Fogelman I. The evaluation of osteoporosis: dual energy x-ray absorptiometry and ultrasound in clinical practice, 2nd ed. London: Martin Dunitz; 1999.
33. Njeh CF, Hans D, Fuerst T, et al.: Quantitative ultrasound: assessment of osteoporosis and bone status. London: Martin Dunitz; 1999.
34. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 1998, 338:736-746.
35. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996, 312:1254-1259.
36. Grampp S, Genant HK, Mathur A, et al.; Comparisons of non-invasive bone mineral measurements in assessing age-related loss, fracture discrimination and diagnostic classification. J Bone Miner Res 1997, 12:697-711.
37. Massie A, Reid DM, Porter RW. Screening for osteoporosis: comparison between dual energy x-ray absorptiometry and broadband ultrasonic attenuation in 1000 perimenopausal women. Osteoporosis Int 1993, 3:107-110.
38. Rosenthall L, Tenenhouse A, Caminis J. A correlative study of ultrasound calcaneal and dual energy x-ray absorptiometry bone measurements of the lumbar spine and femur in 1000 women. Eur J Nucl Med 1995, 22:402-406.
39. Hui SL, Slemenda CW, Johnston CC. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 1988, 81:1804-1809.
40. Ross PD, Davis JW, Epstein RS, et al.: Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991, 114:919-923.
41. Seeley DG, Browner WS, Nevitt MC, et al.: Which fractures are associated with low appendicular bone mass in elderly women? Ann Intern Med 1991, 115:837-842.
42. Cummings SR, Black DM, Nevitt MC, et al.: Bone density at various sites for prediction of hip fractures. Lancet 1993, 341:72-75.
43. Melton LJ, Atkinson EJ, O'Fallon WM, et al.: Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 1993, 8:1227-1233.
44. Nevitt MC, Johnell O, Black DM, et al.: Bone mineral density predicts nonspine fractures in very elderly women. Osteoporosis Int 1994, 4:325-331.
45. Hans D, Dargent-Molina P, Schott AM, et al.: Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 1996, 348:511-514.
46. Bauer DC, Glüer C-C, Cauley JA, et al.: Broadband ultrasonic attenuation predicts fractures strongly and independently of densitometry in older women. Arch Intern Med 1997, 157:629-634.
47. Pluijm SMF, Graafmans WC, Bouter LM, et al.: Ultrasound measurements for the prediction of osteoporotic fractures in elderly people. Osteoporosis Int 1999, 9: 550-556.
48. Blake GM, Fogelman I. Peripheral or central densitometry: does it matter which technique we use? J Clin Densitom 2001, 4:83-96. Discussion of the importance of the relative risk and the ROC curve for comparing different bone densitometry devices and different treatment algorithms.
49. Altman DG. Practical statistics for medical research. London: Chapman Hall; 1991.
50. Black DM, Palermo L, Bauer D. How well does bone mass predict long-term risk of hip fracture? [abstract] Osteoporosis Int 2000, 11 (Suppl 2):S59.
51. Siris ES, Miller PD, Barrett-Connor MD, et al.: Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 2001, 286:2815-2822. First results of the NORA study, a large multicenter study of four different types of peripheral measurement being conducted in the United States.
52. Faulkner K, Abbott TA, Furman WD, et al.: Fracture risk assessment in NORA is comparable across peripheral sites [abstract]. J Bone Miner Res 2000, 15 (Suppl 1): S144.
53. Faulkner KG, VonStetton E, Miller P. Discordance in patient classification using T-scores. J Clin Densitom 1999, 2:343-350.
54. Delmas PD. Do we need to change the WHO definition of osteoporosis? Osteoporosis Int 2000, 11:189-191.
55. Miller PD. Controversies in bone mineral density diagnostic classifications. Calcif Tissue Int 2000, 66:317-319.
56. Frost ML, Blake GM, Fogelman I. Can the WHO criteria for diagnosing osteoporosis be applied to calcaneal quantitative ultrasound? Osteoporosis Int 2000, 11:312-330.
57. Hans D, Rizzoli R, Thiebaud D, et al.: Reference data is a Swiss population: discordance in patient classification using T-scores among calcaneum, spine and femur. J Clin Densitom 2001, 4: 291-298.
58. Kanis JA, Glüer C-C. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporosis Int 2000, 11:192-202.
59. Black DM. Revision of T-score BMD diagnostic thresholds [abstract]. Osteoperosis Int 2000, 11 (Suppl 2):S58.
60. Shepherd JA, Cheng XL, Lu Y, et al.: Universal standardization of forearm bone densitometry. J Bone Miner Res 2002, 17:734-745. First attempt to standardise BMD measurements at a peripheral site for different manufacturers' equipment.
61. Black D, Thompson D, Quandt S, et al.: Alendronate reduces risk of vertebral fracture in women with BMD T-scores above -2.5: results from the fracture intervention trial (FIT) [abstract]. Osteoporesis Int 2002, 13 (Suppl 1):S27. A new analysis of data from the FIT study that shows that for both clinically and radiologically identified vertebral fractures patients responded to treatment equally well whether their baseline T-score was greater than or less than -2.5.
62. Bonnick SL, Johnston CO, Kleerekoper M, et al.: Importance of precision in bone density measurements. J Clin Densitom 2001, 4:105-110. A discussion of the importance of precision for bone densitometry measurements and how it should be measured.
63. Hoskings D, Chilvers CE, Christiansen C, et al.: Prevention of bone loss in postmenopausal women under 60 years of age. Early postmenopausal intervention cohort study group. N Engl J Med 1998, 338:485-492.
64. Blake GM, Herd RJM, Fogelman I. A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total body DXA. Osteoporosis Int 1996, 6:462-470.
65. Faulkner KG. Bone densitometry: choosing the proper skeletal site to measure. J Clin Densitom 1998, 1:279-285.
66. Bouxsein ML, Parker RA, Greenspan SL. Forearm bone mineral densitometry cannot be used to monitor response to alendronate therapy in postmenopausal women. Osteoporosis Int 1999, 10:505-509.
67. Frost ML, Blake GM, Fogelman I. Changes in QUS and BMD measurements with antiresorptive therapy: a two-year longitudinal study, alendronate therapy in postmenopausal women. Calcif Tissue Int 2001, 69:138-146.
68. Bauer DO, Palermo L, Black DM, et al.: A prospective study of dry calcaneal quantitative ultrasound and fracture risk in older women: the Study of Osteoperotic Fractures [abstract]. J Bone Miner Res 2001, 16 (Suppl 1): S166. Results of the SOF study for the prediction of hip fracture risk by a dry heel QUS device. An RR value of only 1.3 was reported which confirmed the disappointing performance of peripheral measurements in recently reported studies.
69. Blake GM, Knapp K, Fogelman I. Should equivalent T-scores be based on absolute fracture risk? [abstract] Osteoporosis Int 2001, 12 (Suppl 2):S8. A study that showed both theoretically and in-vivo that measurements of absolute fracture risk in bone densitometry depend on the RR value of the measurement and the skeletal status of the patient.
70. Looker AC, Wahner HW, Dunn WL, et al.: Updated data on proximal femur bone mineral levels of US adults. Osteoporosis Int 1998, 8:468-489.
71. Cann CE, Genant HK, Kolb FO, et al.: Quantitative computed tomography for prediction of vertebral fracture risk. Bone 1985, 6:1-7.
72. Frost ML, Blake GM, Fogelman I. Contact quantitative ultrasound: an evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteria. Osteoporosis Int 1999, 10:441-449.